Human genetic evidence supports fibroblast growth factor 21 as a novel therapeutic target for gout

被引：0
|
作者：
Zhao, Sizheng Steven [1 ]
Cuthbertson, Daniel J. [2 ,3 ]
Alam, Uazman [3 ,4 ,5 ,6 ]
机构：
[1] Univ Manchester, Fac Biol Med & Hlth, Manchester Acad Hlth Sci Ctr, Sch Biol Sci,Ctr Musculoskeletal Res,Div Musculosk, Oxford Rd, Manchester M13 9LJ, England
[2] Univ Liverpool, Dept Cardiovasc & Metab Med, Liverpool, England
[3] Liverpool Univ Hosp NHS Fdn Trust, Dept Med, Liverpool, England
[4] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Dept Cardiovasc & Metab Med, Liverpool, England
[5] Univ Liverpool, Pain Res Inst, Liverpool, England
[6] Staffordshire Univ, Ctr Biomech & Rehabil Technol, Stoke On Trent, England
来源：
RHEUMATOLOGY | 2024年 / 63卷 / 10期
关键词：
D O I：
10.1093/rheumatology/keae210
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e288 / e289
页数：2
相关论文
共 50 条
  • [21] Fibroblast growth factor 21
    Trusz, Guillaume J.
    [J]. DIFFERENTIATION, 2024, 139
  • [22] A Novel Role for the Fibroblast Growth Factor 21 in Acute Pancreatitis
    Alguel, Hana
    [J]. GASTROENTEROLOGY, 2009, 137 (05) : 1577 - 1579
  • [23] Therapeutic Role of Fibroblast Growth Factor 21 (FGF21) in the Amelioration of Chronic Diseases
    Yeboah Kwaku Opoku
    Zhihang Liu
    Justice Afrifa
    Mir Hassan Khoso
    Guiping Ren
    Deshan Li
    [J]. International Journal of Peptide Research and Therapeutics, 2020, 26 : 107 - 119
  • [24] Therapeutic Role of Fibroblast Growth Factor 21 (FGF21) in the Amelioration of Chronic Diseases
    Opoku, Yeboah Kwaku
    Liu, Zhihang
    Afrifa, Justice
    Khoso, Mir Hassan
    Ren, Guiping
    Li, Deshan
    [J]. INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2020, 26 (01) : 107 - 119
  • [25] Fibroblast growth factor receptor-4 (FGFR-4) as a novel therapeutic target for pancreatic cancer
    Ishiwata, Toshiyuki
    Yoshimura, Hisashi
    Matsuda, Yoko
    Ishiwata, Shunji
    [J]. CANCER RESEARCH, 2016, 76
  • [26] Fibroblast growth factor receptor 1 oncogene partner as a novel prognostic biomarker and therapeutic target for lung cancer
    Mano, Yuria
    Takahashi, Koji
    Ishikawa, Nobuhisa
    Takano, Atsushi
    Yasui, Wataru
    Inai, Kouki
    Nishimura, Hitoshi
    Tsuchiya, Eiju
    Nakamura, Yusuke
    Daigo, Yataro
    [J]. CANCER SCIENCE, 2007, 98 (12): : 1902 - 1913
  • [27] Fibroblast growth factor receptor 3 as a therapeutic target in multiple myeloma.
    Paterson, JL
    Li, ZH
    Bali, M
    Trieu, Y
    Pollett, J
    Stewart, AK
    [J]. BLOOD, 2001, 98 (11) : 773A - 773A
  • [28] Fibroblast growth factor receptors as a potential therapeutic target in patients with intrahepatic cholangiocarcinoma
    Morizane, Chigusa
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [29] Fibroblast Growth Factor Receptor 3 Is a Rational Therapeutic Target in Bladder Cancer
    Gust, Kilian M.
    McConkey, David J.
    Awrey, Shannon
    Hegarty, Paul K.
    Qing, Jing
    Bondaruk, Jolanta
    Ashkenazi, Avi
    Czerniak, Bogdan
    Dinney, Colin P.
    Black, Peter C.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2013, 12 (07) : 1245 - 1254
  • [30] Fibroblast growth factor 21 and its novel association with oxidative stress
    Angel Gomez-Samano, Miguel
    Grajales-Gomez, Mariana
    Maria Zuarth-Vazquez, Julia
    Fernanda Navarro-Flores, Ma
    Martinez-Saavedra, Mayela
    Alfredo Juarez-Leon, Oscar
    Morales-Garcia, Mariana G.
    Manuel Enriquez-Estrada, Victor
    Gomez-Perez, Francisco J.
    Cuevas-Ramos, Daniel
    [J]. REDOX BIOLOGY, 2017, 11 : 335 - 341
12345